Sometimes, beating expectations isn't enough. Just ask Ulta Beauty (ULTA). The beauty retailer's shares took a 10% dive on Friday, a classic case of the market looking past a solid quarterly report and focusing instead on what the boss said about the future.
CEO Kecia Steelman, while optimistic about the company's opportunities, told investors on the earnings call to brace for "ongoing global uncertainty" and "potential economic volatility." She cited "increasingly mindful" concerns over global conflicts and a market that's returning to a more "normalized" state. In investor-speak, "normalized" often translates to "slower growth than the crazy post-pandemic boom," and that's rarely a recipe for a stock rally.
The immediate reaction from Wall Street's analysts was a mix of confirmation and recalibration. Wells Fargo (WFC) analyst Ike Boruchow, who already had an Underweight rating on the stock, saw enough to lower his price target to $475 from $500. On the other side, TD Cowen (COWN)'s Oliver Chen, a bull, reiterated his Buy rating but still trimmed his target to $750 from $775. It's the classic Wall Street move: when in doubt, nudge the target down a bit.
The Numbers Behind the Nerves
So what exactly did Ulta report that got everyone so twitchy? For the fourth quarter, they posted earnings per share of $8.01, which was a hair above the $7.97 analysts were expecting. Revenue came in at $3.898 billion, also beating the consensus estimate of $3.802 billion and up nearly 12% from a year ago.
Comparable sales, a key retail metric, grew 5.8%. That growth came from customers spending a bit more per visit (a 4.2% rise in average ticket) and a slight increase in the number of transactions (up 1.6%).
But here's where the story gets a little less pretty. The gross profit margin slipped ever so slightly to 38.1% from 38.2% a year earlier. The company blamed an "unfavorable channel mix" and higher fixed store costs, though it said those were partly offset by less inventory shrinkage and better supply chain efficiency. Meanwhile, selling, general and administrative (SG&A) expenses jumped 23% to $1.0 billion, driven by more spending on corporate overhead, advertising, and bonuses. The result? Operating income fell to $476.9 million (12.2% of sales) from $516.3 million (14.8% of sales) a year ago.
For the full fiscal year 2025, the picture was stronger. Net sales hit $12.4 billion, up 9.7%, with comp sales growing 5.4%. The full-year gross margin actually improved to 39.1%. But that jump in SG&A for the year (up 17.4%) still weighed on the bottom line.
Looking ahead, the company's guidance for fiscal 2026 was… fine. They forecast earnings per share between $28.05 and $28.55, right around the analyst estimate of $28.38. Revenue is expected to be $13.14 billion to $13.26 billion, also roughly in line with the $13.06 billion Street view. It was a guidance that didn't miss, but it certainly didn't wow anyone either, especially with the CEO's cautious tone layered on top.
What the Charts Are Whispering
If you're into technical analysis, the charts aren't painting a rosy short-term picture either. The stock is now trading well below its key short-term moving averages, a sign the immediate trend has weakened. The Relative Strength Index (RSI) is sitting at 35.92, which is neutral but flirting with oversold territory. More tellingly, the MACD indicator—which tracks momentum—is in a firmly bearish configuration, suggesting the downward pressure might not be over yet.
Technicians are eyeing key support around $493 and resistance up near $612. It's worth remembering, though, that even with this drop, the stock is still up a stunning 79.9% over the past 12 months. This might just be a healthy—if painful—pullback within a longer-term uptrend.
The Analyst Consensus and the ETF Effect
The average analyst price target for Ulta sits at $694.28, and the consensus rating is still a Buy. Recent moves include Telsey Advisory Group maintaining an Outperform rating with a $715 target earlier in March.
Another factor for traders to consider is Ulta's place in the ETF universe. The stock is a notable holding in several funds, including the Franklin US Mid Cap Multifactor Index ETF (FLQM) (1.24% weight), the Invesco NASDAQ Next Gen 100 ETF (QQQJ) (1.50% weight), and the AGF US Market Neutral Anti-Beta Fund ETF (BTAL) (0.58% weight). This means large, automated flows into or out of these ETFs can create built-in buying or selling pressure on Ulta's shares, independent of the company's own news.
At the end of the day, Ulta's story is a familiar one in markets: good numbers met with great caution. The business is still growing, but costs are rising and the macro environment looks foggy. The stock had a phenomenal run, and now investors are deciding if this is a temporary stumble or a sign that the easy growth in the beauty aisle might be getting a bit harder to find. The stock closed Friday down 10.1% at $561.58.
